ARTICLE | Finance
Ebb & Flow
April 6, 2009 7:00 AM UTC
Shares of Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) rode a rollercoaster last week, ultimately finishing down $2.32 (19%) to $9.68, on a mix of clinical, corporate and competitor news.
On Monday, the stock was off by as much as 9% to $10.87 intraday after Amylin announced the nomination of two new board members in its ongoing battle with activist investor Carl Icahn...